220 related articles for article (PubMed ID: 38561859)
41. Knowledge, attitudes, and prescribing patterns of cannabis and cannabinoid-containing medicines among European healthcare workers: a systematic literature review.
Hordowicz M; Klimkiewicz A; Jarosz J; Wysocka M; Jastrzębska M
Drug Alcohol Depend; 2021 Apr; 221():108652. PubMed ID: 33667785
[TBL] [Abstract][Full Text] [Related]
42. Artificial intelligence technologies and compassion in healthcare: A systematic scoping review.
Morrow E; Zidaru T; Ross F; Mason C; Patel KD; Ream M; Stockley R
Front Psychol; 2022; 13():971044. PubMed ID: 36733854
[TBL] [Abstract][Full Text] [Related]
43. Cannabis in End-of-Life Care: Examining Attitudes and Practices of Palliative Care Providers.
Luba R; Earleywine M; Farmer S; Slavin M
J Psychoactive Drugs; 2018; 50(4):348-354. PubMed ID: 29714640
[TBL] [Abstract][Full Text] [Related]
44. Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18).
Lintzeris N; Mills L; Suraev A; Bravo M; Arkell T; Arnold JC; Benson MJ; McGregor IS
Harm Reduct J; 2020 Jun; 17(1):37. PubMed ID: 32513180
[TBL] [Abstract][Full Text] [Related]
45. The effectiveness of health literacy interventions on the informed consent process of health care users: a systematic review protocol.
Perrenoud B; Velonaki VS; Bodenmann P; Ramelet AS
JBI Database System Rev Implement Rep; 2015 Oct; 13(10):82-94. PubMed ID: 26571285
[TBL] [Abstract][Full Text] [Related]
46. Perceived Efficacy of Medical Cannabis in the Treatment of Co-Occurring Health-Related Quality of Life Symptoms.
Bruce D; Foster E; Shattell M
Behav Med; 2021; 47(2):170-174. PubMed ID: 31693457
[TBL] [Abstract][Full Text] [Related]
47. Interventions to increase patient and family involvement in escalation of care for acute life-threatening illness in community health and hospital settings.
Mackintosh NJ; Davis RE; Easter A; Rayment-Jones H; Sevdalis N; Wilson S; Adams M; Sandall J
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012829. PubMed ID: 33285618
[TBL] [Abstract][Full Text] [Related]
48. Medical Cannabis Use: Exploring the Perceptions and Experiences of Older Adults with Chronic Conditions.
Manning L; Bouchard L
Clin Gerontol; 2021; 44(1):32-41. PubMed ID: 33250007
[No Abstract] [Full Text] [Related]
49. Values and preferences towards medical cannabis among people living with chronic pain: a mixed-methods systematic review.
Zeng L; Lytvyn L; Wang X; Kithulegoda N; Agterberg S; Shergill Y; Esfahani MA; Heen AF; Agoritsas T; Guyatt GH; Busse JW
BMJ Open; 2021 Sep; 11(9):e050831. PubMed ID: 34493521
[TBL] [Abstract][Full Text] [Related]
50. Cross national comparison of medical students' attitudes and beliefs about medical cannabis and its application for pain management.
Likhitsathian S; Edelstein OE; Srisurapanont M; Zolotov Y; Karawekpanyawong N; Reznik A; Isralowitz R
Complement Ther Med; 2021 Jun; 59():102720. PubMed ID: 33864906
[TBL] [Abstract][Full Text] [Related]
51. Use of Medical Cannabis by Patients With Cancer: Attitudes, Knowledge, and Practice.
Cohen T; Ezra MB; Yanai S; Oren-Azulay T; Wein S; Hamama-Raz Y
J Pain Symptom Manage; 2023 Sep; 66(3):203-211.e1. PubMed ID: 37244526
[TBL] [Abstract][Full Text] [Related]
52. Chronic Pain Clinical and Prescriptive Practices in the Cannabis Era.
Aebischer JH; Dieckmann NF; Jones KD; St John AW
Pain Manag Nurs; 2022 Apr; 23(2):109-121. PubMed ID: 34973920
[TBL] [Abstract][Full Text] [Related]
53. Medical cannabis education among healthcare trainees: A scoping review.
Zolotov Y; Metri S; Calabria E; Kogan M
Complement Ther Med; 2021 May; 58():102675. PubMed ID: 33539943
[TBL] [Abstract][Full Text] [Related]
54. Attitudes and beliefs of medicine and social work students about medical cannabis use for epilepsy.
Edelstein OE
Epilepsy Behav; 2022 Feb; 127():108522. PubMed ID: 34999501
[TBL] [Abstract][Full Text] [Related]
55. Provision and uptake of routine antenatal services: a qualitative evidence synthesis.
Downe S; Finlayson K; Tunçalp Ö; Gülmezoglu AM
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012392. PubMed ID: 31194903
[TBL] [Abstract][Full Text] [Related]
56. Cannabis-based medicines and medical cannabis for patients with neuropathic pain and other pain disorders: Nationwide register-based pharmacoepidemiologic comparison with propensity score matched controls.
Hjorthøj C; La Cour P; Nordentoft M; Posselt CM
Eur J Pain; 2022 Feb; 26(2):480-491. PubMed ID: 34624164
[TBL] [Abstract][Full Text] [Related]
57. Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain.
Petzke F; Tölle T; Fitzcharles MA; Häuser W
CNS Drugs; 2022 Jan; 36(1):31-44. PubMed ID: 34802112
[TBL] [Abstract][Full Text] [Related]
58. Meta-Synthesis on Migraine Management.
Minen MT; Anglin C; Boubour A; Squires A; Herrmann L
Headache; 2018 Jan; 58(1):22-44. PubMed ID: 29159874
[TBL] [Abstract][Full Text] [Related]
59. [Are schizophrenic patients being told their diagnosis today in France?].
Villani M; Kovess-Masféty V
Encephale; 2017 Apr; 43(2):160-169. PubMed ID: 27372353
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
